Advanced Immunotherapeutics

Tustin, CA 92782

SBIR Award Summary

Total Number of Awards 3
Total Value of Awards $0.0
First Award Date 09/29/91
Most Recent Award Date 08/01/94

Key Personnel

Last Name Name Awards Contact
Glasky Alvin J Glasky 3

3 Awards Won

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 08/01/94 - 10/31/95

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 08/09/93 - 07/31/94

The long-term objective of this program is to develop a drug for the treatment of memory deficits associated with aging and Alzheimer's disease. Loss of working memory represents the core early symptom of Alzheimer's disease. AIT-082 is a unique purine derivative that specifically enhances working memory in normals animals, restores working me...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/29/91 - 03/31/92

DESCRIPTION: (Adapted from Applicant's Abstract) The applicant proposes to develop AIT-082 for the treatment of dementia due to Alzheimer's disease, stroke or aging. In Phase I, he plans to complete the preclinical studies needed to submit an Investigational New Drug (IND) exemption application to the Food and Drug Administration (FDA). Speci...